Literature DB >> 23849774

ox-LDL induces PiT-1 expression in human aortic valve interstitial cells.

Nicole A Nadlonek1, Joon H Lee, Michael J Weyant, Xianzhong Meng, David A Fullerton.   

Abstract

BACKGROUND: The aortic valve interstitial cell (AVIC) has been implicated in the pathogenesis of calcific aortic stenosis. When appropriately stimulated, AVICs undergo a phenotypic change from that of a myofibroblast to that of a bone-forming-like cell. An elevated blood level of low-density lipoprotein (LDL) cholesterol is a clinical risk factor for aortic stenosis, and oxidized LDL (ox-LDL) cholesterol has been consistently found in calcified aortic valve leaflets. However, whether it plays a role in the pathogenesis of aortic stenosis is unknown. The process of aortic valve leaflet calcification has been associated with the deposition of calcium phosphate, mediated in part by the phosphate inorganic transporter 1 (PiT-1), a sodium-phosphate ion cotransporter. Therefore, we hypothesized that ox-LDL induces an osteogenic change in human AVICs marked by the induction of PiT-1. Using isolated human AVICs, the purpose of the present study was to examine the effect of ox-LDL on the expression of PiT-1 and the osteogenic factor bone morphogenetic protein 2 (BMP-2), which is a protein necessary for bone formation.
METHODS: Human AVICs were isolated from nonstenotic aortic valves obtained from the explanted hearts of patients undergoing cardiac transplantation (n = 4) and grown in culture. The cells were treated with serum-free media, serum-free media with dimethyl sulfoxide (vehicle control), 40 μg/mL of ox-LDL, or 40 μg/mL of ox-LDL plus 2.5 mM phosphonoformate hexahydrate acid. Phosphonoformate hexahydrate acid is a competitive inhibitor of PiT-1 by mimicking inorganic phosphate. Cell lysis was performed at 24 h after treatment. Cell lysates were analyzed using immunoblot and densitometry for PiT-1 and BMP-2. Statistical analysis was performed using analysis of variance. P < 0.05 was significant.
RESULTS: ox-LDL stimulation of AVICs induced an increase in PiT-1 and BMP-2. ox-LDL induced increased production of the phosphate transporter, PiT-1, and the osteogenic factor, BMP-2. Inhibition of PiT-1 with phosphonoformate hexahydrate acid prevented ox-LDL-induced BMP-2 expression.
CONCLUSIONS: These data offer mechanistic insight into the pathogenesis of calcific aortic stenosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Aortic valve interstitial cell; Oxidized low-density lipoprotein cholesterol; Phosphate inorganic transporter 1

Mesh:

Substances:

Year:  2013        PMID: 23849774      PMCID: PMC3879113          DOI: 10.1016/j.jss.2013.05.001

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  16 in total

1.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; J Thyberg; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

2.  Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition.

Authors:  Ricardo Villa-Bellosta; Víctor Sorribas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-12       Impact factor: 8.311

3.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Authors:  Anne B Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Journal:  N Engl J Med       Date:  2008-09-02       Impact factor: 91.245

Review 4.  Molecular mechanisms underlying the onset of degenerative aortic valve disease.

Authors:  Daihiko Hakuno; Naritaka Kimura; Masatoyo Yoshioka; Keiichi Fukuda
Journal:  J Mol Med (Berl)       Date:  2008-09-03       Impact factor: 4.599

5.  Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis.

Authors:  Ashok N Babu; Xianzhong Meng; Ning Zou; Xiaoping Yang; Maorong Wang; Yong Song; Joseph C Cleveland; Michael Weyant; Anirban Banerjee; David A Fullerton
Journal:  Ann Thorac Surg       Date:  2008-07       Impact factor: 4.330

6.  Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis.

Authors:  Xianzhong Meng; Lihua Ao; Yong Song; Ashok Babu; Xiaoping Yang; Maorong Wang; Michael J Weyant; Charles A Dinarello; Joseph C Cleveland; David A Fullerton
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-17       Impact factor: 4.249

7.  Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.

Authors:  Dania Mohty; Philippe Pibarot; Jean-Pierre Després; Claude Côté; Benoit Arsenault; Amélie Cartier; Pierre Cosnay; Christian Couture; Patrick Mathieu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-01       Impact factor: 8.311

8.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

9.  Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis.

Authors:  Jens J Kaden; Carl-Erik Dempfle; Rainer Grobholz; Hanh-Thai Tran; Refika Kiliç; Aslihan Sarikoç; Martina Brueckmann; Christian Vahl; Siegfried Hagl; Karl K Haase; Martin Borggrefe
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

10.  Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.

Authors:  C Côté; P Pibarot; J-P Després; D Mohty; A Cartier; B J Arsenault; C Couture; P Mathieu
Journal:  Heart       Date:  2007-10-11       Impact factor: 5.994

View more
  8 in total

Review 1.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

2.  Association Between Lipoprotein(a) and Calcific Aortic Valve Disease: A Systematic Review and Meta-Analysis.

Authors:  Qiyu Liu; Yanqiao Yu; Ruixi Xi; Jingen Li; Runmin Lai; Tongxin Wang; Yixuan Fan; Zihao Zhang; Hao Xu; Jianqing Ju
Journal:  Front Cardiovasc Med       Date:  2022-04-25

Review 3.  Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.

Authors:  Calvin Yeang; Michael J Wilkinson; Sotirios Tsimikas
Journal:  Curr Opin Cardiol       Date:  2016-07       Impact factor: 2.161

Review 4.  Innate and adaptive immunity in cardiovascular calcification.

Authors:  Livia S A Passos; Adrien Lupieri; Dakota Becker-Greene; Elena Aikawa
Journal:  Atherosclerosis       Date:  2020-02-28       Impact factor: 5.162

Review 5.  Innate and Adaptive Immunity in Calcific Aortic Valve Disease.

Authors:  Patrick Mathieu; Rihab Bouchareb; Marie-Chloé Boulanger
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

Review 6.  Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification.

Authors:  Arkady Rutkovskiy; Anna Malashicheva; Gareth Sullivan; Maria Bogdanova; Anna Kostareva; Kåre-Olav Stensløkken; Arnt Fiane; Jarle Vaage
Journal:  J Am Heart Assoc       Date:  2017-09-14       Impact factor: 5.501

7.  Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.

Authors:  Takuma Matsumura; Jiro Terada; Taku Kinoshita; Yoriko Sakurai; Misuzu Yahaba; Kenji Tsushima; Seiichiro Sakao; Kengo Nagashima; Toshinori Ozaki; Yoshio Kobayashi; Takaki Hiwasa; Koichiro Tatsumi
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

Review 8.  The mechanistic pathways of oxidative stress in aortic stenosis and clinical implications.

Authors:  Kailun Phua; Nicholas Ws Chew; William Kf Kong; Ru-San Tan; Lei Ye; Kian-Keong Poh
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.